DENVER, CO, March 01, 2021 /AxisWire/ -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma company in the life sciences category committed to the research and development, production, and acceptance of alternative...
Toronto, Canada - September 15, 2020 /AxisWire/ Mydecine Innovations Group Inc. (MYCO.CN) (MYCOF) (0NF.F) ("Mydecine" or the "Company"), is pleased to announce that it’s subsidiary Mindleap Health has implemented a comprehensive information security rollout of next-generation cyber-security solutions to meet ...
Being Facilitated Under a Schedule 1 Health Canada Dealer’s License DENVER, Colorado, USA, August 18, 2020 /AxisWire/ Mydecine Innovations Group, Inc., (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) ("Mydecine™" or the "Company") is pleased to announce it is the first organization to exercise its cGMP(₁)...
DENVER, Colorado, July 31, 2020 /AxisWire/ - Mydecine Innovations Group™ Inc. (CSE: MYCO) (OTC: NLBIF) (FSE:0NF) ("Mydecine"), is pleased to announce that its subsidiary, Mindleap Health™ (“Mindleap” or the “Company”) based in Vancouver, British Columbia, is expanding it’s digital therapeutic...
DENVER, CO - July 24, 2020/AxisWire/ - Mydecine Innovations Group Inc. (CSE: MYCO) (OTC: MYCOF) (FSE:0NF) ("Mydecine" or the "Company"), is pleased to announce that they have hired former Red Bull marketing executive, Jim Gunning, as the Company’s new Chief...
Vancouver - July 21, 2020 /AxisWire/ Mydecine Innovations Group Inc. (CSE: MYCO) (OTCMKTS: MYCOF) (FSE:0NF) (“Mydecine” or the “Company”) is pleased to announce that its subsidiary Mindleap Health Inc. ( “Mindleap” ) has signed an agreement dated July xx, 2020 ...
VANCOUVER, British Columbia - June 30, 2020/AxisWire/ - Mydecine Innovations Group Inc. (CSE: MYCO) (OTC: MYCOF) (FSE:0NF) ("Mydecine" or the "Company"), is pleased to announce that it has added world renowned drug discovery expert Dr. Denton Hoyer to its Scientific...